Results 281 to 290 of about 227,212 (304)

Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells

Circulation, 2021
Liqun He, Alison Daniels, Sarah Fletcher   +2 more
exaly  

Angiotensin‐Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID‐19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System

Journal of the American Heart Association, 2021
Jaejin An, Rong Wei, Hui Zhou
exaly  

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Circulation Research, 2020
Peng Zhang, Lihua Zhu, Jingjing Cai
exaly  

Angiotensin-converting enzyme inhibitors

Journal of the American Academy of Dermatology, 1994
openaire   +2 more sources

Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents

Hypertension, 2008
JOSÉ A Hernández Prada, Michael J Katovich, Vinayak Shenoy   +2 more
exaly  

Angiotensin I Converting Enzyme

1989
R A, Skidgel, E G, Erdös
openaire   +2 more sources

Loss of Angiotensin-Converting Enzyme-2 Exacerbates Diabetic Cardiovascular Complications and Leads to Systolic and Vascular Dysfunction

Circulation Research, 2012
Vaibhav B Patel, Sreedhar Bodiga, Ratnadeep Basu   +2 more
exaly  

MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension

Circulation, 2020
Pritesh P Jain, Mingmei Xiong, Kaizheng Gong   +2 more
exaly  

Inhibitors of Angiotensin-Converting Enzyme

1980
D W, Cushman, M A, Ondetti, H S, Cheung, M J, Antonaccio, V S, Murthy, B, Rubin   +5 more
openaire   +2 more sources

Association Between Angiotensinogen, Angiotensin II Receptor Genes, and Blood Pressure Response to an Angiotensin-Converting Enzyme Inhibitor

Circulation, 2007
Liming Lee, Jun Lv
exaly